20 May 2022 , 01:46 PM
Net profit of Hester Biosciences declined 20.33% to Rs 7.72 crore in the quarter ended March 2022 as against Rs 9.69 crore during the previous quarter ended March 2021. Sales declined 12.01% to Rs 56.47 crore in the quarter ended March 2022 as against Rs 64.18 crore during the previous quarter ended March 2021. For the full year,net profit rose 14.20% to Rs 39.32 crore in the year ended March 2022 as against Rs 34.43 crore during the previous year ended March 2021. Sales rose 9.65% to Rs 235.01 crore in the year ended March 2022 as against Rs 214.33 crore during the previous year ended March 2021.
| Particulars | Quarter Ended | Year Ended | ||||
| ? | Mar. 2022 | Mar. 2021 | % Var. | Mar. 2022 | Mar. 2021 | % Var. |
| Sales | 56.47 | 64.18 | -12 | 235.01 | 214.33 | 10 |
| OPM % | 18.28 | 30.80 | – | 25.53 | 32.03 | – |
| PBDT | 16.44 | 20.82 | -21 | 70.08 | 66.74 | 5 |
| PBT | 11.31 | 17.19 | -34 | 53.50 | 53.42 | 0 |
| NP | 7.72 | 9.69 | -20 | 39.32 | 34.43 | 14 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
